IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Sakar Healthcare IPO is a Book Building listing on NSE EMERGE exchange, with an ipo size of ₹ 14.81 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Sakar Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 7th October 2016.
Sakar Healthcare IPO posted revenues of ₹ 41.22 Cr. and PAT of ₹ 2.32 Cr. in FY25 on annualised basis.
Revenue:
₹ 41.22 Cr.
EBITDA Margin:
20.69
% 
Net Worth: ₹ 17.15 Cr.
Market Capitalisation:
[●]
P/E:
23.00 times
P/BV: [●]
EV/EBITDA: 2.24 times
Financial results of Sakar Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY16 | FY15 | FY14 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 51.11 | 50.17 | 52.33 | ||
| Net Worth | 17.15 | 14.82 | 12.99 | ||
| Total Debt | 19.33 | 24.74 | 24.31 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
41.22 | 35.02 | 29.68 | ||
EBITDA
EBITDA on annualised basis |
8.53 | 7.85 | 8.62 | ||
PAT
PAT on annualised basis |
2.32 | 1.83 | 1.75 | ||
Sakar Healthcare IPO PAT Margin is 5.63 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Sakar Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY16 | FY15 | FY14 |
|---|---|---|---|
| EBITDA Margin (%) | 20.69 | 22.42 | 29.04 |
| PAT Margin (%) | 5.63 | 5.23 | 5.90 |
| EPS (₹) | 2.91 | 2.30 | 2.19 |
| ROE (%) | 13.53 | 12.35 | 13.47 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 4.54 | 3.65 | 3.34 |
| Debt to Equity | 1.13 | 1.67 | 1.87 |
The market Capitalisation of Sakar Healthcare IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Sakar Healthcare IPO prospectus highlights an Return on Equity (ROE) of 13.53 % , Return on Assets (ROA) of 4.54 %, and an EBITDA Margin of 20.69 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Sakar Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Sakar Healthcare IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Sakar Healthcare IPO has a Price-to-Earnings (PE) ratio of 23.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Sakar Healthcare IPO reported revenue of ₹ 41.43 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Sakar Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Sakar Healthcare recorded an EBITDA of ₹ 8.53 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Sakar Healthcare Profit After Tax (PAT) is ₹ 2.32 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 41.22 Cr.
EBITDA Margin:
20.69
%
Net Worth: ₹ 17.15 Cr.
Market Capitalisation:
[●]
P/E:
23.00 times
P/BV: [●]
EV/EBITDA:
[●]
Sakar Healthcare operates in Pharmaceutical and Manufacturing And Marketing Of Its Pharmaceutical Formulations For Domestic And International Market. The Issue is listed on NSE EMERGE in Oct, 2016. Sakar Healthcare IPO size was 14.81 with Issue price of 50.00 .
Merchant Banker(s) of Sakar Healthcare IPO: Pantomath Capital Advisors Private Limited
Sakar Healthcare IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sakar Healthcare IPO listed at a listing price of 52.15 against the offer price of 50.00.
The current market price of Sakar Healthcare is 353.40.
Why Us?
